









市場
/
株式
/
nasdaq-ebs
/

Emergent BioSolutions Inc

EBS

12.430USD

-0.200-1.58%

終値 12/26, 16:00（ET）15分遅れの株価

655.06M時価総額

8.75直近12ヶ月PER



Emergent BioSolutions Inc

12.430

-0.200-1.58%

概要企業名金融分析

概要

企業名

金融

分析

詳細情報 Emergent BioSolutions Inc 企業名

Emergent BioSolutions, Inc. is a life sciences company. It is focused on providing preparedness and response solutions addressing accidental, deliberate and naturally occurring public health threats. Its solutions include a product portfolio, a product development portfolio, and a contract development and manufacturing services portfolio. Its segments include Commercial Products, MCM Products, and Services segment. Its Commercial Product segment consists of NARCAN Nasal Spray. Its MCM Products segment consists of Anthrax MCM products, Smallpox MCM products and Other Products. Its Services segment consists of its Bioservices portfolio. NARCAN (naloxone HCl) Nasal Spray, an intranasal formulation of naloxone, is developed for the emergency treatment of known or suspected opioid overdose as manifested by respiratory and central nervous system depression. Its Bioservices consist of development services, bulk drug substance manufacturing, fill, finish, and packaging of final drug products.

Emergent BioSolutions Incの企業情報



企業コードEBS

会社名Emergent BioSolutions Inc

上場日Nov 15, 2006

最高経営責任者「CEO」Papa (Joseph C)

従業員数900

証券種類Ordinary Share

決算期末Nov 15

本社所在地300 Professional Dr

都市GAITHERSBURG

証券取引所NASDAQ OMX NASDAQ Basic NYSE

国United States of America

郵便番号20879

電話番号12406313200

ウェブサイトhttps://emergentbiosolutions.com/

企業コードEBS

上場日Nov 15, 2006

最高経営責任者「CEO」Papa (Joseph C)

Emergent BioSolutions Incの経営陣



会社名

会社名/ポジション

ポジション

株式保有

変動額

Mr. Joseph C. (Joe) Papa

President, Chief Executive Officer, Director

342.50K

+21.24%

Mr. Richard S. (Rich) Lindahl

Chief Financial Officer, Executive Vice President, Treasurer

196.50K

-2.48%

Dr. Zsolt Harsanyi, Ph.D.

Independent Chairman of the Board

103.49K

+49.80%

Dr. Simon C Lowry, M.D.

Chief Medical Officer, Head of Research and Development

91.98K

+211.99%

Ms. Coleen Glessner

Executive Vice President - Quality and Ethics and Compliance

90.86K

-25.20%

Mr. Ronald B. Richard

Independent Director

78.17K

-8.33%

Ms. Jessica Perl

Senior Vice President, General Counsel, Corporate Secretary

68.39K

+1061.66%

Mr. Marvin L. White

Independent Director

68.25K

+101.64%

Mr. Keith A. Katkin, CPA

Independent Director

66.14K

-10.60%

Mr. William Hartzel

Senior Vice President - Manufacturing and Bioservices

62.55K

-0.97%

詳細を見る

会社名

会社名/ポジション

ポジション

株式保有

変動額

Mr. Joseph C. (Joe) Papa

President, Chief Executive Officer, Director

342.50K

+21.24%

Mr. Richard S. (Rich) Lindahl

Chief Financial Officer, Executive Vice President, Treasurer

196.50K

-2.48%

Dr. Zsolt Harsanyi, Ph.D.

Independent Chairman of the Board

103.49K

+49.80%

Dr. Simon C Lowry, M.D.

Chief Medical Officer, Head of Research and Development

91.98K

+211.99%

Ms. Coleen Glessner

Executive Vice President - Quality and Ethics and Compliance

90.86K

-25.20%

Mr. Ronald B. Richard

Independent Director

78.17K

-8.33%

収益内訳

通貨: USD更新時刻: Mon, Oct 6

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

事業別USD

会社名

収益

比率

Commercial Product sales

67.50M

47.91%

MCM Product sales

58.40M

41.45%

Contracts and grants

15.00M

10.65%

地域別USD

会社名

収益

比率

Non-U.S Government

83.10M

58.98%

U.S.Government

57.80M

41.02%

事業別

地域別

事業別USD

会社名

収益

比率

Commercial Product sales

67.50M

47.91%

MCM Product sales

58.40M

41.45%

Contracts and grants

15.00M

10.65%

株主

更新時刻: Mon, Nov 17

株主統計

種類

株主統計

比率

BlackRock Institutional Trust Company, N.A.

7.43%

The Vanguard Group, Inc.

6.74%

State Street Investment Management (US)

4.66%

American Century Investment Management, Inc.

4.54%

Dimensional Fund Advisors, L.P.

4.08%

他の

72.56%

株主統計

比率

BlackRock Institutional Trust Company, N.A.

7.43%

The Vanguard Group, Inc.

6.74%

State Street Investment Management (US)

4.66%

American Century Investment Management, Inc.

4.54%

Dimensional Fund Advisors, L.P.

4.08%

他の

72.56%

種類

株主統計

比率

Investment Advisor

34.85%

Investment Advisor/Hedge Fund

30.34%

Hedge Fund

7.25%

Individual Investor

2.97%

Research Firm

1.58%

Pension Fund

1.08%

Bank and Trust

0.83%

Sovereign Wealth Fund

0.18%

Family Office

0.07%

他の

20.85%

機関投資家保有株



更新時刻: Mon, Dec 8

報告期間

機関投資家数

保有株式数

比率

変動額

2025Q4

378

39.86M

83.14%

+128.30K

2025Q3

417

39.73M

84.87%

+2.04M

2025Q2

439

37.58M

87.40%

+1.14M

2025Q1

454

36.44M

84.55%

-9.64M

2024Q4

461

35.04M

82.31%

+2.84M

2024Q3

467

32.21M

81.37%

+1.29M

2024Q2

485

30.86M

99.60%

-5.54M

2024Q1

494

36.44M

103.37%

-17.72M

2023Q4

512

41.89M

103.68%

-1.06M

2023Q3

563

42.52M

113.85%

-6.21M

詳細を見る

株主動向



会社名

保有株式数

比率

変動額

変動率

日付

BlackRock Institutional Trust Company, N.A.

3.83M

7.18%

+2.25M

+141.83%

Jun 30, 2025

The Vanguard Group, Inc.

3.58M

6.72%

+370.21K

+11.52%

Jun 30, 2025

State Street Investment Management (US)

1.74M

3.26%

+30.01K

+1.75%

Jun 30, 2025

American Century Investment Management, Inc.

2.29M

4.3%

-5.46K

-0.24%

Jun 30, 2025

Dimensional Fund Advisors, L.P.

1.85M

3.47%

+252.40K

+15.81%

Jun 30, 2025

Palisade Capital Management, LLC

1.10M

2.06%

-41.83K

-3.66%

Jun 30, 2025

Charles Schwab Investment Management, Inc.

1.11M

2.07%

+521.91K

+89.48%

Jun 30, 2025

Geode Capital Management, L.L.C.

1.28M

2.4%

+666.71K

+108.89%

Jun 30, 2025

Acadian Asset Management LLC

974.59K

1.83%

+141.27K

+16.95%

Jun 30, 2025

Connor, Clark & Lunn Investment Management Ltd.

986.67K

1.85%

+55.05K

+5.91%

Jun 30, 2025

詳細を見る

配当金



過去5年間の配当金総支払額は 0.00 米ドルである。

日付

配当金

権利確定日

支払日

配当落ち日

データなし

株式分割



日付

種類

比率

データなし

日付

種類

比率

データなし

よくある質問

Emergent BioSolutions Incの上位5名の株主は誰ですか？



Emergent BioSolutions Incの上位5名の株主は以下のとおりです。
BlackRock Institutional Trust Company, N.A.は3.83M株を保有しており、これは全体の7.18%に相当します。
The Vanguard Group, Inc.は3.58M株を保有しており、これは全体の6.72%に相当します。
State Street Investment Management (US)は1.74M株を保有しており、これは全体の3.26%に相当します。
American Century Investment Management, Inc.は2.29M株を保有しており、これは全体の4.30%に相当します。
Dimensional Fund Advisors, L.P.は1.85M株を保有しており、これは全体の3.47%に相当します。